Karyopharm Therapeutics Inc.
KPTI
•Stock Analysis$5.93
+0.00 (+0.00%)• Live
Karyopharm Therapeutics Inc. Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for Karyopharm Therapeutics Inc.
Key Financial Metrics
for Karyopharm Therapeutics Inc.
P/E Ratio
-8.56
Revenue Growth
-0.55%
EPS Growth
+49.60%
Market Cap
$0.04B
Dividend Yield
0.00%
Debt/Equity
-0.44
ROIC
-310.56%
FCF Yield
-323.48%
View additional metrics
Valuation
P/B Ratio-2.60
EV/Sales0.64
Financial Health
Current Ratio1.33
Return on Assets-48.96%
Analyst Recommendations
for Karyopharm Therapeutics Inc.
20 analysts
Consensus: Buy
About
for Karyopharm Therapeutics Inc.
Company Details
for Karyopharm Therapeutics Inc.
Sector
Healthcare
Industry
Biotechnology
CEO
Richard A. Paulson
Employees
279
Market Cap
51.42M
Exchange
NASDAQ Global Select
IPO Date
November 6, 2013
Website
www.karyopharm.comCIK
0001503802
ISIN
US48576U2050
CUSIP
48576U205
Country
US
Balance Sheet
for Karyopharm Therapeutics Inc.
Cash Flow Statement
for Karyopharm Therapeutics Inc.
Income Statement
for Karyopharm Therapeutics Inc.
News
No news available at the moment.